NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,241 | -95.5% | 3,029 | -89.1% | 0.00% | – |
| Q2 2023 | $72,151 | +42.6% | 27,911 | +125.1% | 0.00% | – |
| Q1 2023 | $50,600 | -13.2% | 12,402 | +6.9% | 0.00% | – |
| Q4 2022 | $58,262 | -61.4% | 11,606 | 0.0% | 0.00% | – |
| Q3 2022 | $151,000 | +10.2% | 11,606 | +8.8% | 0.00% | – |
| Q2 2022 | $137,000 | -14.4% | 10,666 | +1.4% | 0.00% | – |
| Q1 2022 | $160,000 | -14.0% | 10,518 | 0.0% | 0.00% | – |
| Q4 2021 | $186,000 | -15.8% | 10,518 | 0.0% | 0.00% | – |
| Q3 2021 | $221,000 | +154.0% | 10,518 | +136.1% | 0.00% | – |
| Q2 2021 | $87,000 | +8.8% | 4,455 | +62.5% | 0.00% | – |
| Q1 2021 | $80,000 | -7.0% | 2,742 | -3.8% | 0.00% | – |
| Q4 2020 | $86,000 | +91.1% | 2,850 | 0.0% | 0.00% | – |
| Q3 2020 | $45,000 | -40.0% | 2,850 | -24.9% | 0.00% | – |
| Q2 2020 | $75,000 | +53.1% | 3,794 | +1.2% | 0.00% | – |
| Q1 2020 | $49,000 | -46.7% | 3,749 | -25.1% | 0.00% | – |
| Q4 2019 | $92,000 | +557.1% | 5,006 | +400.6% | 0.00% | – |
| Q3 2019 | $14,000 | -6.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |